Therapeutic Potential of Select Berry Varieties in Mitigating Cognitive Decline via Oxidative Stress and Insulin Resistance in AlCl 3 ‐Exposed Mice
Brain and Behavior · 2026-04 · 16 (4)
DOI: 10.1002/brb3.71411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 21.04.2026. Verfasst von Sawsan G A A Mohammed und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Science Department, QU Health, College of Medicine, Qatar University, Doha, Qatar. Hauptthemen laut MEDLINE: Oxidative Stress, Insulin Resistance, Fruit, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Oxidative stress damage and impaired insulin receptor (IR) signaling are critical risk factors for contributing to cognitive impairment in Alzheimer's disease (AD) and other neurological disorders. The beta‐amyloid peptide (Aβ) oligomer deposition in the hippocampal region decreases the IR expression. This study aimed to assess whether berries grown in Oman ( Morus alba , Morus macroura , and Sideroxylon mascatense ) could ameliorate dysfunction of the antioxidant system and restore the IR expression thereby improve the cognitive performance in aluminum chloride (AlCl 3 ) induced AD mouse model.
Methods
Various biochemical assays were conducted to estimate antioxidant capacity. The total phenolic (TPC) and flavonoid (TFC) contents for the three varieties were quantified using Folin–Ciocalteu and AlCl 3 calorimetric methods, respectively. The antioxidant properties of the three berries were analyzed using thiobarbituric acid reactive substances assay (TBARS), superoxide dismutase assay (SOD), glutathione assay (GSH), glutathione peroxidase assay (GPx), and estimation of glutathione reductase (GR). Cognitive performance was measured using Morris water maze (MWM) and T‐maze.
Findings
Berries, particularly M. alba and S. mascatense , demonstrated the highest phenolic and flavonoid content and exhibited strong antioxidant activity across all assays. Mice fed with M. alba , M. macroura , and S. mascatense showed better performance parameters in both MWM (spatial learning and memory) and T‐maze (time taken to reach the platform) tests, along with enhanced IR signaling ( p < 0.01).
Conclusion
These findings suggest that supplementation with mulberries may improve cognitive decline and insulin resistance induced by AlCl 3 , highlighting their potential as neuroprotective agents in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Science Department, QU Health, College of Medicine, Qatar University, Doha, Qatar.
- Healix Lab, Muscat, Oman.
- Healthcare Research & Policy Division, Q3 Research Institute (QRI), Ann Arbor, Michigan, USA.
- Department of Chemistry, College of Science, Sultan Qaboos University, Muscat, Oman.
- Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
ORCID-Profile: Sawsan G A A Mohammed, M Walid Qoronfleh, Reem Al Alawi
Zitieren
APA
Mohammed, S. G. A. A., Qoronfleh, M. W., Alawi, R. A., & Al-Siyabi, S. (2026). Therapeutic Potential of Select Berry Varieties in Mitigating Cognitive Decline via Oxidative Stress and Insulin Resistance in AlCl 3 ‐Exposed Mice. Brain and Behavior, 16(4). https://doi.org/10.1002/brb3.71411
Vancouver
Mohammed SGAA, Qoronfleh MW, Alawi RA, Al-Siyabi S. Therapeutic Potential of Select Berry Varieties in Mitigating Cognitive Decline via Oxidative Stress and Insulin Resistance in AlCl 3 ‐Exposed Mice. Brain and Behavior. 2026;16(4). doi:10.1002/brb3.71411
BibTeX
@article{Mohammed2026,
author = {Mohammed, Sawsan G A A and Qoronfleh, M Walid and Alawi, Reem Al and Al-Siyabi, Shadhan},
title = {Therapeutic Potential of Select Berry Varieties in Mitigating Cognitive Decline via Oxidative Stress and Insulin Resistance in AlCl 3 ‐Exposed Mice},
journal = {Brain and Behavior},
year = {2026},
volume = {16},
number = {4},
doi = {10.1002/brb3.71411}
}
EUVIMED